Girl, You Could Be That One: Merck’s One Less Campaign
Throughout the years prior to 2006, the amount of people being infected with human papillomavirus, or more commonly known as HPV, has been increasing. Even though HPV has been the subject of talk shows and school health lectures, at least 20 million Americans a year get infected with this virus. According to the Center for Disease Control, out of the 20 million Americans suffering from HPV each year, at least 33,300 cancer cases first root from HPV ("HPV-Associated Cancers Statistics,” par.1). These alarming statistics prompted Merck to release the first vaccine that could protect against the transmission of HPV in June 2006, called Gardasil. The release and availability of this vaccine started Merck’s One Less campaign. Through Merck’s effective marketing strategies, television commercials, and most importantly, communication amongst the general public, Gardasil has been proven to have reduced the number of people battling HPV and cancer. According to the Center for Disease Control, human papillomavirus or HPV is ranked one of the most common sexually transmitted infections in the United States. This virus has more than a hundred different types and results ("HPV Symptoms & Tests in Women & Men,” par. 2). HPV not only weakens the immune system, but it can also cause health problems such as genital warts and certain types of cancers, depending male or female. In many cases, since the symptoms of HPV are not very evident and will eventually go away, many people are infected by this sexually transmitted infection (STI) and do not even know it. The lack of symptoms and knowledge are what causes HPV to be spread so easily and quickly. Often, when people find out that they have been infected, it is too late (“HPV and Cancer,” par. 1-2). As the HPV statistics continued to rise, Merck introduced a new vaccine that was able to defend people, mainly women, from HPV. After much research, Merck informed the...
Cited: "Cervical Cancer Rates by Race and Ethnicity." Centers for Disease Control and Prevention. Centers for Disease Control and Prevention, 12 Aug. 2013. Web. 16 Jan. 2014.
Chen, Christine. “How did you learn about the vaccine Gardasil?.” Survey. 16 Jan. 2014.
"Gardasil (Human Papillomavirus Vaccine) Questions and Answers." FDA U.S. Food and Drug Administration. FDA, 12 Aug. 2013. Web. 17 Jan. 2014.
Grantham, Susan, Ahern, Lee, and Connolly-Ahern, Collen. “Merck’s One Less Campaign: Using Risk Message Frames to Promote the Use of Garasil in HPV Prevention.” Communication Research Reports 28.4 (2011): 318-326. Print.
"HPV and Cancer." National Cancer Institute. National Cancer Institute, n.d. Web. 15 Jan. 2014.
"HPV-Associated Cancers Statistics." Centers for Disease Control and Prevention. Centers for Disease Control and Prevention, 18 July 2013. Web. 15 Jan. 2014.
"HPV Symptoms & Tests in Women & Men." WebMD. WebMD, n.d. Web. 17 Jan. 2014.
"Merck Launches National Advertising Campaign For GARDASIL®, Merck 's New Cervical Cancer Vaccine." Medical News Today. MediLexicon International, 23 Nov. 2006. Web. 17 Jan. 2014.
"Press Release." Centers for Disease Control and Prevention. Centers for Disease Control and Prevention, 19 June 2013. Web. 15 Jan. 2014.
Please join StudyMode to read the full document